SureTrader SureTrader
Home > Boards > US Listed > Biotechs > Peregrine Pharmaceuticals (PPHM)

To quote Mark Twain, "The rumors of my

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
stoneroad Member Profile
Member Level 
Followed By 39
Posts 4,209
Boards Moderated 0
Alias Born 02/12/09
160x600 placeholder
Peregrine Pharmaceuticals Provides Update on Oral Presentation of Top-Line Data from Phase III SUNRISE Trial of Bavituximab a... "GlobeNewswire Inc." - 9/21/2016 8:05:00 AM
Peregrine Pharmaceuticals Reports Financial Results for First Quarter of Fiscal Year 2017 and Recent Developments "GlobeNewswire Inc." - 9/8/2016 4:05:00 PM
Peregrine Pharmaceuticals Declares Quarterly Dividend on Its Series E Convertible Preferred Stock "GlobeNewswire Inc." - 9/6/2016 4:05:00 PM
National Comprehensive Cancer Network (NCCN) Awards Three Grants for Combination Studies of Peregrine Pharmaceuticals’ Bavi... "GlobeNewswire Inc." - 9/6/2016 8:45:00 AM
Peregrine to Report Financial Results for First Quarter of Fiscal Year 2017 After Market Close on September 8, 2016 "GlobeNewswire Inc." - 9/1/2016 4:05:00 PM
Avid Bioservices to Participate in Cambridge Healthtech Institute’s (CHI) 8th Annual The Bioprocessing Summit "GlobeNewswire Inc." - 8/9/2016 8:05:00 AM
Peregrine Pharmaceuticals Reports Financial Results for Quarter and Fiscal Year Ended April 30, 2016 and Recent Developments "GlobeNewswire Inc." - 7/14/2016 4:05:00 PM
Peregrine Licenses Novel Exosome-Based Cancer Detection and Monitoring Technology from UT Southwestern Medical Center "GlobeNewswire Inc." - 7/14/2016 8:05:00 AM
Peregrine to Report Financial Results for the Quarter and Fiscal Year Ended April 30, 2016 After Market Close on July 14, 201... "GlobeNewswire Inc." - 7/7/2016 4:05:00 PM
Peregrine Pharmaceuticals Declares Quarterly Dividend on Its Series E Convertible Preferred Stock "GlobeNewswire Inc." - 6/2/2016 4:00:00 PM
Peregrine Pharmaceuticals Provides Corporate Update Highlighting Latest Developments for Contract Manufacturing and Drug Deve... "GlobeNewswire Inc." - 6/2/2016 8:05:00 AM
Preclinical Data Presented at American Association for Cancer Research (AACR) Annual Meeting Demonstrate Enhanced Therapeutic... "GlobeNewswire Inc." - 4/20/2016 8:05:00 AM
Form 8-K - Current report "Edgar (US Regulatory)" - 4/12/2016 4:31:41 PM
Peregrine Pharmaceuticals Declares Quarterly Dividend on Its Series E Convertible Preferred Stock "GlobeNewswire Inc." - 3/9/2016 7:46:45 PM
Peregrine Pharmaceuticals Announces Formal Commissioning of New, State-of-the-Art Commercial Manufacturing Facility "GlobeNewswire Inc." - 3/9/2016 7:46:43 PM
Peregrine to Report Financial Results for Third Quarter of Fiscal Year 2016 Prior to Market Open on March 9, 2016 "GlobeNewswire Inc." - 3/9/2016 7:46:38 PM
Peregrine Pharmaceuticals Provides Update on Phase III SUNRISE Trial of Bavituximab "GlobeNewswire Inc." - 3/9/2016 7:46:14 PM
Peregrine Pharmaceuticals Reports Financial Results for Third Quarter of Fiscal Year 2016 and Recent Developments "GlobeNewswire Inc." - 3/9/2016 8:00:00 AM
Peregrine Alert -- National Securities Law Firm Continues Investigation of Peregrine Pharmaceuticals, Inc. for Potential Secu... "PR Newswire (US)" - 2/29/2016 9:30:00 AM
Peregrine Alert -- National Securities Law Firm Investigates Peregrine Pharmaceuticals, Inc. for Potential Securities Law Cla... "PR Newswire (US)" - 2/26/2016 3:09:00 PM
Four Biotech Small Caps with Near Term Catalysts to Keep on Your Radar "InvestorsHub NewsWire" - 1/27/2016 8:00:00 AM
Peregrine Pharmaceuticals to Present at Two Upcoming Cancer Immunotherapy Conferences "GlobeNewswire Inc." - 1/20/2016 8:05:00 AM
Peregrine Pharmaceuticals Provides Update on Planned Expansion of Bavituximab Clinical Program in Lung, Breast and Other Canc... "GlobeNewswire Inc." - 1/11/2016 8:05:00 AM
Peregrine Pharmaceuticals and National Comprehensive Cancer Network (NCCN) Form Clinical Collaboration to Evaluate Novel Canc... "GlobeNewswire Inc." - 1/6/2016 8:05:00 AM
Peregrine Pharmaceuticals Reports Financial Results for Second Quarter of Fiscal Year 2016 and Recent Developments "GlobeNewswire Inc." - 12/10/2015 4:05:00 PM
stoneroad Member Level  Tuesday, 09/25/12 09:40:05 AM
Re: None
Post # of 273361 
To quote Mark Twain, "The rumors of my death have been greatly exagerated".

SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist